open access

Vol 71, No 5 (2020)
Clinical vignette
Submitted: 2020-06-17
Accepted: 2020-06-20
Early publication date: 2020-08-27
Get Citation

Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumour in a patient with type 1 diabetes

Zoltan Herold1, Andrea Uhlyarik1, Magdolna Herold1, Peter Nagy2, Gergely Denes Huszty3, Klara Rosta4, Marton Doleschall5, Aniko Somogyi1
DOI: 10.5603/EP.a2020.0054
·
Pubmed: 32856287
·
Endokrynol Pol 2020;71(5):483-484.
Affiliations
  1. Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary
  2. 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
  3. Department of Transplantation and Surgery, Semmelweis University, Budapest, 1082, Hungary
  4. Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria
  5. Molecular Medicine Research Group, Eotvos Lorand Research Network and Semmelweis University, Budapest, Hungary

open access

Vol 71, No 5 (2020)
Clinical Vignette
Submitted: 2020-06-17
Accepted: 2020-06-20
Early publication date: 2020-08-27

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

chromogranin A; diabetes mellitus type 1; enterochromaffin-like cells; atrophic gastritis; neuroendocrine tumours

About this article
Title

Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumour in a patient with type 1 diabetes

Journal

Endokrynologia Polska

Issue

Vol 71, No 5 (2020)

Article type

Clinical vignette

Pages

483-484

Early publication date

2020-08-27

Page views

734

Article views/downloads

408

DOI

10.5603/EP.a2020.0054

Pubmed

32856287

Bibliographic record

Endokrynol Pol 2020;71(5):483-484.

Keywords

chromogranin A
diabetes mellitus type 1
enterochromaffin-like cells
atrophic gastritis
neuroendocrine tumours

Authors

Zoltan Herold
Andrea Uhlyarik
Magdolna Herold
Peter Nagy
Gergely Denes Huszty
Klara Rosta
Marton Doleschall
Aniko Somogyi

References (5)
  1. Wang R, Zheng-Pywell R, Chen HA, et al. Management of Gastrointestinal Neuroendocrine Tumors. Clin Med Insights Endocrinol Diabetes. 2019; 12: 1179551419884058.
  2. Herold Z, Doleschall M, Kovesdi A, et al. Chromogranin A and its role in the pathogenesis of diabetes mellitus. Endokrynol Pol. 2018; 69(5): 598–610.
  3. Herold Z, Herold M, Nagy P, et al. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis. J Diabetes Investig. 2019 [Epub ahead of print].
  4. De Block CEM, Colpin G, Thielemans K, et al. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes. Diabetes Care. 2004; 27(6): 1387–1393.
  5. Bizzaro N, Antico A, Villalta D. Autoimmunity and Gastric Cancer. Int J Mol Sci. 2018; 19(2).

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl